Inari Medical, Inc.: investing cash flow

What this measure means

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Exact concept: us-gaap:NetCashProvidedByUsedInInvestingActivities. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2018-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.

This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.

Selected filing history

Related financial histories

• Inari Medical, Inc.: total assets
• Inari Medical, Inc.: total liabilities
• Inari Medical, Inc.: stockholders equity
• Inari Medical, Inc.: cash and cash equivalents
• Inari Medical, Inc.: net income or loss
• Inari Medical, Inc.: operating cash flow
• Inari Medical, Inc.: capital expenditure payments
• Inari Medical, Inc.: revenue
• Inari Medical, Inc.: contract revenue excluding tax
• Inari Medical, Inc.: financing cash flow
• Inari Medical, Inc.: retained earnings or deficit
• Inari Medical, Inc.: basic weighted-average shares
• Inari Medical, Inc.: diluted weighted-average shares
• Inari Medical, Inc.: basic earnings per share
• Inari Medical, Inc.: diluted earnings per share
• Inari Medical, Inc.: income tax expense or benefit
• Inari Medical, Inc.: net property, plant and equipment
• Inari Medical, Inc.: share-based compensation expense
• Inari Medical, Inc.: operating income or loss
• Inari Medical, Inc.: current assets
• Inari Medical, Inc.: interest expense
• Inari Medical, Inc.: current liabilities
• Inari Medical, Inc.: current accounts payable
• Inari Medical, Inc.: net current accounts receivable
• Inari Medical, Inc.: operating expenses
• Inari Medical, Inc.: net inventory
• Inari Medical, Inc.: gross profit
• Inari Medical, Inc.: selling, general and administrative expense
• Inari Medical, Inc.: research and development expense
• Inari Medical, Inc.: common shares outstanding
• Inari Medical, Inc.: cash including restricted cash
• Inari Medical, Inc.: accumulated other comprehensive income or loss
• Inari Medical, Inc.: operating lease right-of-use asset
• Inari Medical, Inc.: operating lease liability
• Inari Medical, Inc.: gross property, plant and equipment
• Inari Medical, Inc.: accumulated depreciation on property, plant and equipment
• Inari Medical, Inc.: net intangible assets excluding goodwill
• Inari Medical, Inc.: other noncurrent liabilities
• Inari Medical, Inc.: prepaid expenses and other current assets
• Inari Medical, Inc.: pre-tax income or loss from continuing operations
• Inari Medical, Inc.: profit or loss including noncontrolling interests
• Inari Medical, Inc.: comprehensive income or loss
• Inari Medical, Inc.: depreciation expense
• Inari Medical, Inc.: depreciation, depletion and amortization
• Inari Medical, Inc.: amortization of intangible assets
• Inari Medical, Inc.: other nonoperating income or expense
• Inari Medical, Inc.: current income tax expense or benefit
• Inari Medical, Inc.: deferred income tax expense or benefit
• Inari Medical, Inc.: interest paid, net
• Inari Medical, Inc.: income taxes paid, net
• Inari Medical, Inc.: operating lease payments
• Inari Medical, Inc.: change in accounts receivable
• Inari Medical, Inc.: change in inventories
• Inari Medical, Inc.: change in accounts payable

Inspect the source

Entity

Inari Medical, Inc. / CIK 0001531048

Captured

2026-09-21T17:20:30.731Z

SEC response SHA-256

a421f2bd4ef46d6837857ff241ab74711b4b21b90d8476b41e202f8359e0dc6d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001531048.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))